Gravier Pierre

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 87% 68% 82%
Transactions
7 14% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 83%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Gravier Pierre's trades of PTC Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
347.92
Quantity 38,121 -30.9%
Value US$4,157,297
Transaction date
Proposed sale
Price
68.73
Quantity 82,951
Value US$3,707,693
Transaction date
Sale
Price
348.44
Quantity 57,093 -43.4%
Value US$2,432,829
Transaction date
Proposed sale
Price
69.36
Quantity 2,992
Value US$207,515
Transaction date
Sale
Price
76.95
Quantity 2,139 -2.3%
Value US$164,596
Transaction date
Proposed sale
Price
76.95
Quantity 2,139
Value US$164,591
Transaction date
Sale
Price
49.46
Quantity 2,516 -3.4%
Value US$124,441
Transaction date
Proposed sale
Price
49.46
Quantity 2,516
Value US$124,435
Transaction date
Sale
Price
50.12
Quantity 1,167 -1.5%
Value US$58,495
Transaction date
Proposed sale
Price
50.12
Quantity 1,167
Value US$58,495
Transaction date
Sale
Price
50.10
Quantity 1,168 -1.5%
Value US$58,512
Transaction date
Proposed sale
Price
50.10
Quantity 1,168
Value US$58,513
Transaction date
Sale
Price
34.02
Quantity 2,269 -4.1%
Value US$77,200
Transaction date
Proposed sale
Price
34.02
Quantity 2,269
Value US$77,200
Transaction date
Purchase
Price
25.81
Quantity 7,700 +29.6%
Value US$198,736
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-16 2026-07-14
PlS Planned sale
38,121 -30.9%
347.92
US$4,157,297 		38,121 -30.9% 347.92 US$4,157,297
2026-07-14 2026-07-14
PrS Proposed sale
82,951
68.73
US$3,707,693 		82,951 68.73 US$3,707,693
2026-02-20 2026-02-18
S Sale
57,093 -43.4%
348.44
US$2,432,829 		57,093 -43.4% 348.44 US$2,432,829
2026-02-18 2026-02-18
PrS Proposed sale
2,992
69.36
US$207,515 		2,992 69.36 US$207,515
2026-01-08 2026-01-06
S Sale
2,139 -2.3%
76.95
US$164,596 		2,139 -2.3% 76.95 US$164,596
2026-01-06 2026-01-06
PrS Proposed sale
2,139
76.95
US$164,591 		2,139 76.95 US$164,591
2025-07-17 2025-07-15
S Sale
2,516 -3.4%
49.46
US$124,441 		2,516 -3.4% 49.46 US$124,441
2025-07-15 2025-07-15
PrS Proposed sale
2,516
49.46
US$124,435 		2,516 49.46 US$124,435
2025-02-21 2025-02-20
S Sale
1,167 -1.5%
50.12
US$58,495 		1,167 -1.5% 50.12 US$58,495
2025-02-20 2025-02-20
PrS Proposed sale
1,167
50.12
US$58,495 		1,167 50.12 US$58,495
2025-02-21 2025-02-19
S Sale
1,168 -1.5%
50.10
US$58,512 		1,168 -1.5% 50.10 US$58,512
2025-02-19 2025-02-19
PrS Proposed sale
1,168
50.10
US$58,513 		1,168 50.10 US$58,513
2024-07-18 2024-07-16
S Sale
2,269 -4.1%
34.02
US$77,200 		2,269 -4.1% 34.02 US$77,200
2024-07-16 2024-07-16
PrS Proposed sale
2,269
34.02
US$77,200 		2,269 34.02 US$77,200
2023-12-14 2023-12-12
B Purchase
7,700 +29.6%
25.81
US$198,736 		7,700 +29.6% 25.81 US$198,736